Industry Insights - Pharma & Life Sciences

5 key steps to improve literature screening workflows for safety signal detection can positively impact the whole life cycle of a drug. ...

ErbB1 kinase is the cell-surface receptor for epidermal growth factor. Its dysfunction has been implicated in diseases such as cancer. ...

Effective drug discovery depends on a deep understanding of the function and therapeutic potential of a compound. ...

The first marketed selective T-type calcium channel blocker mibefradil was withdrawn due to adverse drug interactions. ...

Most traditional drugs act on more than one target, exhibiting a complex, multifaceted pharmacological profile. ...

In silico techniques require exhaustive data and sophisticated, well-structured informatics tools to help scientists gain insights of compound behavior. ...

Cancer is often viewed as one monolithic disease, but every cancer is unique. Therapies with accurate diagnosis are needed to effectively fight the disease ...

Biases and heterogeneity in the data of spontaneous adverse event reporting systems can make it hard to gain the insights to inform decisions. ...

Despite growing scientific insight and technological investment, attempts to develop novel therapies still show limited success. ...

Biological researchers face growing body of scientific literature that they must search through in order to keep up with developments in their field. ...

Preclinical safety programs often follow a standard template to determine off-target effects. ...

The scope of what pharmacovigilance leaders must consider has greatly increased as regulatory agencies worldwide have broadened their expectations. ...

The vision for precision medicine is that it will offer improved treatments for patients, while also optimizing the drug development process as a whole. ...

By boosting anti-cancer response using a patient’s own immune system, immunotherapeutics are showing incredible promise ...

Precision medicine has significantly progressed in the last several years as it has become possible to find more tailored treatments for patients ...